Increased risk for early hypertriglyceridemia in small for gestational age preterm infants
- 1 December 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Pediatrics
- Vol. 179 (12), 1873-1879
- https://doi.org/10.1007/s00431-020-03764-8
Abstract
Small for gestational age preterm are at increased risk for future metabolic syndrome. Early indication for the disrupted metabolism may be found in the perinatal period. We aimed to evaluate whether small for gestational age preterm infants are at increased risk for hypertriglyceridemia when treated with lipid emulsions, and to investigate the association between triglyceride levels and morbidity. Small for gestational age infants <= 34 weeks' gestation age born during 2013-2016 were matched and compared with appropriate for gestational age counterparts. Triglyceride concentration > 250 mg/dL during treatment with parenteral nutrition was considered high. The study included 71 pairs of preterm infants. Hypertriglyceridemia was documented among 22.5% of the small for gestational age infants vs. 5.6% of the appropriate for gestational age infants (p = 0.007). Mean triglyceride levels were 194.4 +/- 192.3 mg/dL and 99.9 +/- 82.8 mg/dL, respectively (p < 0.001). Small for gestational age was predictive of hypertriglyceridemia (OR = 6.41; 95% CI 1.8-22.9). No significant association was found between triglyceride levels and morbidities in multivariate analysis. Conclusion: Small for gestational age preterm infants receiving lipid emulsions might be at a higher risk for hypertriglyceridemia. Routine monitoring of triglyceride levels will enable identification of the necessity for a slower increase in lipid emulsion therapy. What is Known: center dot Moderate and very preterm infants are routinely treated with lipid emulsions. center dot Small for gestational age (SGA) infants may have different metabolism, as they demonstrate higher risk for metabolic syndrome. What is New: center dot center dot SGA infants had a higher mean triglyceride level and more commonly had early hypertriglyceridemia (triglycerides > 250 mg/dL) compared with appropriate for gestational age infants treated with the same intravenous lipid dose. Small for gestational age was predictive of hypertriglyceridemia. center dot No significant association was found between triglyceride levels and morbidities in multivariate analysis.This publication has 28 references indexed in Scilit:
- Safety and Efficacy of Early Parenteral Lipid and High-Dose Amino Acid Administration to Very Low Birth Weight InfantsThe Journal of Pediatrics, 2013
- Fetal Programming and Metabolic SyndromeAnnual Review of Physiology, 2012
- Fetal Origins of Adult DiseaseCurrent Problems in Pediatric and Adolescent Health Care, 2011
- Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1JCI Insight, 2008
- Gender-specific programmed hepatic lipid dysregulation in intrauterine growth-restricted offspringAmerican Journal of Obstetrics and Gynecology, 2007
- The developmental origins of adult disease (Barker) hypothesisAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2006
- Cord Blood Lipids Concentrations and Their Relation to Body Size at Birth: Possible Link between Intrauterine Life and Adult DiseasesAmerican Journal of Perinatology, 2004
- Lipoprotein profile and cholesteryl ester transfer protein in neonatesMetabolism, 2001
- Altered cord serum lipid levels associated with small for gestational age infantsObstetrics & Gynecology, 1999
- Tolerance of Fat Emulsions in Very Low Birthweight Neonates: Effect of Birthweight on Plasma Lipid ConcentrationsAmerican Journal of Perinatology, 1990